ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 18.95
+0.05 (0.26%)
Sep 30, 2025, 2:36 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 14.98 billion as of September 30, 2025. Its market cap has decreased by -25.10% in one year.
Market Cap
14.98B
Enterprise Value
12.62B
Revenue
3.19B
Ranking
n/a
PE Ratio
73.21
Stock Price
18.95
Market Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 14.98B, a decrease of -50.77%. That is a compound annual growth rate of -4.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 14.98B | -14.06% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | 22.81B | 8.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 286.16B |
| PharmaEssentia | 189.36B |
| Bora Pharmaceuticals Co., LTD. | 84.40B |
| Lotus Pharmaceutical | 67.06B |
| Lumosa Therapeutics | 48.18B |
| Oneness Biotech | 32.14B |
| Polaris Group | 28.58B |
| Center Laboratories | 27.60B |